Mitologics is an innovative biotechnology company based in Paris area (France) focusing on detection of mitochondrial injury, a key regulator of cell death. Mitologics proposes screening services to detect the toxicity and efficacy of compounds by predictive assays on isolated healthy or pathological mitochondrial and cellular models. Mitologics assays on isolated mitochondria from mouse liver and human hepatocytes are highly predictive of hepatotoxicity in human (Porceddu et al., 2012). Three proprietary screening platforms: • MiToxView®: predictive toxicity assays • MitoPathway®: efficacy assays on tumor mitochondria • MitoXpert®: mitochondrial targeting/protection.